Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin
Journal of Antimicrobial Chemotherapy · 01.02.2024 · 79 (2) · 403-411
DOI: 10.1093/jac/dkad395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 28.12.2023. Verfasst von Francesca Romana Massacci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche 'Togo Rosati', Perugia, Italy. Hauptthemen laut MEDLINE: Streptococcus suis, Aminoacyltransferases, Cephalosporins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Background
Streptococcus suis is an important pig pathogen and an emerging zoonotic agent. In a previous study, we described a high proportion of penicillin-resistant serotype 9 S. suis (SS9) isolates on pig farms in Italy.
Objectives
We hypothesized that resistance to penicillin emerged in some SS9 lineages characterized by substitutions at the PBPs, contributing to the successful spread of these lineages in the last 20 years.
Methods
Sixty-six SS9 isolates from cases of streptococcosis in pigs were investigated for susceptibility to penicillin, ceftiofur and ampicillin. The isolates were characterized for ST, virulence profile, and antimicrobial resistance genes through WGS. Multiple linear regression models were employed to investigate the associations between STs, year of isolation, substitutions at the PBPs and an increase in MIC values to β-lactams.
Results
MIC values to penicillin increased by 4% each year in the study period. Higher MIC values for penicillin were also positively associated with ST123, ST1540 and ST1953 compared with ST16. The PBP sequences presented a mosaic organization of blocks. Within the same ST, substitutions at the PBPs were generally more frequent in recent isolates. Resistance to penicillin was driven by substitutions at PBP2b, including K479T, D512E and K513E, and PBP2x, including T551S, while reduced susceptibility to ceftiofur and ampicillin were largely dependent on substitutions at PBP2x.
Conclusions
Here, we identify the STs and substitutions at the PBPs responsible for increased resistance of SS9 to penicillin on Italian pig farms. Our data highlight the need for monitoring the evolution of S. suis in the coming years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche 'Togo Rosati', Perugia, Italy.
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Parma, Italy.
- Istituto Zooprofilattico Sperimentale delle Venezie, Padova, Italy.
ORCID-Profile: Francesca Romana Massacci
Förderung
- Italian Ministry of Health
Zitieren
APA
Massacci, F. R., Cucco, L., Panicciá, M., Luppi, A., Albini, E., Peruzzo, A., Ferroni, L., Ustulin, M., Orsini, M., & Magistrali, C. F. (2024). Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin. Journal of Antimicrobial Chemotherapy, 79(2), 403-411. https://doi.org/10.1093/jac/dkad395
Vancouver
Massacci FR, Cucco L, Panicciá M, Luppi A, Albini E, Peruzzo A, et al. Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin. Journal of Antimicrobial Chemotherapy. 2024;79(2):403-411. doi:10.1093/jac/dkad395
BibTeX
@article{Massacci2024,
author = {Massacci, Francesca Romana and Cucco, Lucilla and Panicciá, Marta and Luppi, Andrea and Albini, Elisa and Peruzzo, Arianna and Ferroni, Laura and Ustulin, Martina and Orsini, Massimiliano and Magistrali, Chiara Francesca},
title = {Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
volume = {79},
number = {2},
pages = {403--411},
doi = {10.1093/jac/dkad395}
}
EUVIMED